← All trials

NCT05455697

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jan 7, 2023
Primary completion
Jan 5, 2026
Completion date
Jul 6, 2026
First posted
Jul 13, 2022
Last posted
Dec 9, 2022
Enrollment
35
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.